Humana (FRA:HUM) ROCE %: % (As of Mar. 2026)


FRA:HUM Humana Inc FRA:HUM
87 GF Score
Price €338.00
GF Value €315.58
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Humana ROCE %?

Humana FRA:HUM +1.20% 87 ROCE % is % as of Mar. 2026. GuruFocus rates FRA:HUM with a GF Score™ of 87/100 and a GF Value™ of €315.58 (Fairly Valued). The stock has 7 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

FRA:HUM
87GF Score
Humana Inc FRA:HUM
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
Humana (FRA:HUM) has a ROCE % of % as of Mar. 2026.
Is Humana's ROCE % too high?
Humana's current ROCE % is %. Overall, Humana has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Humana's ROCE % compare to CNC and CI?
Humana's ROCE % of % can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana stock overvalued right now?
Based on GuruFocus' analysis, Humana (FRA:HUM) is currently considered Fairly Valued. The stock's GF Value™ is €315.58, compared to a current price of €338.00 — trading 7.1% above its estimated fair value. The current ROCE % is %. Humana's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Humana (FRA:HUM), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Humana (FRA:HUM) Overvalued in 2026?

Based on GuruFocus' analysis, Humana stock appears to be overvalued. The current stock price of €338.00 is trading 7.1% above its estimated GF Value™ of €315.58. GuruFocus considers Humana to be Fairly Valued.

Key valuation signals for FRA:HUM:

  • ROCE %: %
  • GF Value™: €315.58 vs. price of €338.00 (7.1% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the FRA:HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Humana Business Description

Address 101 East Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
87GF Score

Get the complete analysis for FRA:HUM

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€338.00
Price
€315.58
GF Value